Baxter International Inc. recently recalled certain lots of two intravenous solutions distributed to U.S. customers and distributors between June 6 and Dec. 16, which may contain particulate matter, the Food and Drug Administration reports. The company directed customers not to use product from the two recalled lots, which may be returned for credit. Any associated adverse reactions or quality problems may be reported to the FDA’s MedWatch program.